Laura E. Fredenburgh

7.1k total citations · 2 hit papers
64 papers, 3.9k citations indexed

About

Laura E. Fredenburgh is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Laura E. Fredenburgh has authored 64 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 26 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in Laura E. Fredenburgh's work include Respiratory Support and Mechanisms (14 papers), Heme Oxygenase-1 and Carbon Monoxide (11 papers) and Pulmonary Hypertension Research and Treatments (11 papers). Laura E. Fredenburgh is often cited by papers focused on Respiratory Support and Mechanisms (14 papers), Heme Oxygenase-1 and Carbon Monoxide (11 papers) and Pulmonary Hypertension Research and Treatments (11 papers). Laura E. Fredenburgh collaborates with scholars based in United States, South Korea and Japan. Laura E. Fredenburgh's co-authors include Mark A. Perrella, Rebecca M. Baron, Augustine M.K. Choi, Daniel J. Tschumperlin, S. Alex Mitsialis, Kyoung Moo Choi, Koichi Fukunaga, Bruce D. Levy, Payal Kohli and Xaralabos Varelas and has published in prestigious journals such as Journal of the American Chemical Society, Circulation and Nature Communications.

In The Last Decade

Laura E. Fredenburgh

61 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis

2014 617 citations Fei Liu, David Lagares et al. American Journal of Physiology-Lung Cellular and Molecular Physiology profile →
Inflammasome-regulated Cytokines Are Critical Mediators of Acute Lung Injury

2012 434 citations Tamás Dolinay, Young Sam Kim et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura E. Fredenburgh United States	32	1.5k	1.2k	533	490	486	64	3.9k
Elizabeth R. Jacobs United States	44	1.5k 1.0×	1.2k 1.0×	465 0.9×	743 1.5×	176 0.4×	156	5.7k
Hermann Pavenstädt Germany	38	2.2k 1.4×	687 0.6×	408 0.8×	631 1.3×	472 1.0×	167	6.7k
Julie A. Reisz United States	42	2.4k 1.6×	691 0.6×	605 1.1×	435 0.9×	354 0.7×	168	5.9k
Vijay V. Kakkar United Kingdom	37	1.6k 1.0×	455 0.4×	650 1.2×	510 1.0×	292 0.6×	193	5.5k
Eisei Noiri Japan	50	2.1k 1.3×	745 0.6×	647 1.2×	1.0k 2.0×	372 0.8×	205	8.2k
Robert M. Jackson United States	31	1.7k 1.1×	1.1k 1.0×	413 0.8×	389 0.8×	201 0.4×	123	4.6k
Libor Vı́tek Czechia	46	4.5k 2.9×	986 0.8×	288 0.5×	1.0k 2.1×	688 1.4×	246	7.6k
Börje Haraldsson Sweden	39	1.5k 1.0×	861 0.7×	373 0.7×	255 0.5×	532 1.1×	153	6.3k
Li Ma China	40	1.7k 1.1×	383 0.3×	446 0.8×	448 0.9×	356 0.7×	172	4.9k
Saurabh Aggarwal United States	36	1.4k 0.9×	1.0k 0.9×	426 0.8×	519 1.1×	138 0.3×	152	4.2k

Countries citing papers authored by Laura E. Fredenburgh

Since Specialization

Citations

This map shows the geographic impact of Laura E. Fredenburgh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Fredenburgh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Fredenburgh more than expected).

Fields of papers citing papers by Laura E. Fredenburgh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura E. Fredenburgh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Fredenburgh. The network helps show where Laura E. Fredenburgh may publish in the future.

Co-authorship network of co-authors of Laura E. Fredenburgh

This figure shows the co-authorship network connecting the top 25 collaborators of Laura E. Fredenburgh. A scholar is included among the top collaborators of Laura E. Fredenburgh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura E. Fredenburgh. Laura E. Fredenburgh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aravamudhan, Aja, Paul B. Dieffenbach, Kyoung Moo Choi, et al.. (2024). Non‐canonical IKB kinases regulate YAP/TAZ and pathological vascular remodeling behaviors in pulmonary artery smooth muscle cells. Physiological Reports. 12(7). e15999–e15999. 2 indexed citations

Aymonnier, Karen, Julie Ng, Laura E. Fredenburgh, et al.. (2022). Inflammasome activation in neutrophils of patients with severe COVID-19. Blood Advances. 6(7). 2001–2013. 63 indexed citations

Shen, Yuanjun, Dmitry A. Goncharov, Andressa Peña, et al.. (2022). Cross-talk between TSC2 and the extracellular matrix controls pulmonary vascular proliferation and pulmonary hypertension. Science Signaling. 15(763). eabn2743–eabn2743. 14 indexed citations

Sigurðsson, Martin I., H. Kobayashi, Karin Amrein, et al.. (2022). Circulating N-formylmethionine and metabolic shift in critical illness: a multicohort metabolomics study. Critical Care. 26(1). 321–321. 16 indexed citations

Rehman, Rakhshinda, et al.. (2021). Abstract 14210: Impaired Mitophagy and Reduced Parkin Expression in Human Pulmonary Arterial Smooth Muscle Cells (PASMCs) in Pulmonary Arterial Hypertension (PAH). Circulation. 144(Suppl_1). 1 indexed citations

Torres, Lisa K., Eric A. Hoffman, Clara Oromendia, et al.. (2021). Attributable mortality of acute respiratory distress syndrome: a systematic review, meta-analysis and survival analysis using targeted minimum loss-based estimation. Thorax. 76(12). 1176–1185. 23 indexed citations

Rehman, Rakhshinda, Ashish Jaiswal, Vaibhav Jain, et al.. (2020). Noncanonical role for Ku70/80 in the prevention of allergic airway inflammation via maintenance of airway epithelial cell organelle homeostasis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 319(4). L728–L741. 7 indexed citations

Hudalla, Hannes, Zoe Michael, Nicolas Christodoulou, et al.. (2019). Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension. American Journal of Respiratory Cell and Molecular Biology. 61(4). 512–524. 60 indexed citations

Mason, Stefanie, Paul B. Dieffenbach, Joshua A. Englert, et al.. (2019). Semi-quantitative visual assessment of chest radiography is associated with clinical outcomes in critically ill patients. Respiratory Research. 20(1). 218–218. 14 indexed citations

10.

Schenck, Edward J., C. Kevin, David R. Price, et al.. (2019). Circulating cell death biomarker TRAIL is associated with increased organ dysfunction in sepsis. JCI Insight. 4(9). 30 indexed citations

11.

Sicard, Delphine, et al.. (2018). Aging and anatomical variations in lung tissue stiffness. American Journal of Physiology-Lung Cellular and Molecular Physiology. 314(6). L946–L955. 106 indexed citations

12.

Johansson, Pär I., Kiichi Nakahira, Angela J. Rogers, et al.. (2018). Plasma mitochondrial DNA and metabolomic alterations in severe critical illness. Critical Care. 22(1). 360–360. 35 indexed citations

13.

Lasky‐Su, Jessica, Amber Dahlin, Augusto A. Litonjua, et al.. (2017). Metabolome alterations in severe critical illness and vitamin D status. Critical Care. 21(1). 193–193. 39 indexed citations

14.

Ghanta, Sailaja, Konstantin Tsoyi, Xiaoli Liu, et al.. (2016). Mesenchymal Stromal Cells Deficient in Autophagy Proteins Are Susceptible to Oxidative Injury and Mitochondrial Dysfunction. American Journal of Respiratory Cell and Molecular Biology. 56(3). 300–309. 37 indexed citations

15.

Dalli, Jesmond, Bryan Kraft, Romain A. Colas, et al.. (2015). The Regulation of Proresolving Lipid Mediator Profiles in Baboon Pneumonia by Inhaled Carbon Monoxide. American Journal of Respiratory Cell and Molecular Biology. 53(3). 314–325. 53 indexed citations

16.

Liu, Fei, David Lagares, Kyoung Moo Choi, et al.. (2014). Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 308(4). L344–L357. 617 indexed citations breakdown →

17.

Haspel, Jeffrey A., Sukrutha Chettimada, Rahamthulla S. Shaik, et al.. (2014). Circadian rhythm reprogramming during lung inflammation. Nature Communications. 5(1). 4753–4753. 169 indexed citations

18.

Dolinay, Tamás, Young Sam Kim, Judie A. Howrylak, et al.. (2012). Inflammasome-regulated Cytokines Are Critical Mediators of Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 185(11). 1225–1234. 434 indexed citations breakdown →

19.

Fredenburgh, Laura E., Olin D. Liang, Alvaro A. Macias, et al.. (2008). Absence of Cyclooxygenase-2 Exacerbates Hypoxia-Induced Pulmonary Hypertension and Enhances Contractility of Vascular Smooth Muscle Cells. Circulation. 117(16). 2114–2122. 67 indexed citations

20.

Fukunaga, Koichi, Payal Kohli, Caroline Bonnans, Laura E. Fredenburgh, & Bruce D. Levy. (2005). Cyclooxygenase 2 Plays a Pivotal Role in the Resolution of Acute Lung Injury. The Journal of Immunology. 174(8). 5033–5039. 234 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact